ABOUT THIS EPISODE
An exclusive conversation with Dr. Bonnie LaFleur, Associate Professor of Biostatistics at the University of Arizona, to discuss the randomized clinical trial she is leading. This trial, funded by philanthropy from R. Ken Coit, will enroll more than 700 older adults to determine whether rapamycin improves resilience and immune aging.
DISCLAIMER: The information provided on Longevity Science with Matt Kaeberlein is intended solely for general educational purposes and is not meant to be, nor should it be construed as, personalized medical advice. No doctor-patient relationship is established by your use of this channel. The information and materials presented are for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. We strongly advise that you consult with a licensed healthcare professional for all matters concerning your health, especially before undertaking any changes based on content provided by this channel. The hosts and guests on this channel are not liable for any direct, indirect, or other damages or adverse effects that may arise from the application of the information discussed. Medical knowledge is constantly evolving; therefore, the information provided should be verified against current medical standards and practices.More places to find us:Twitter: https://twitter.com/mkaeberleinLinkedIn: https://www.linkedin.com/in/mkaeberlein/Instagram: https://www.instagram.com/mkaeberlein/
YouTube: https://www.youtube.com/@mkaeberlein
